US Patent Issued to Akebia Therapeutics on Nov. 25 for "Prolyl hydroxylase inhibitors and methods of use" (Missouri, Colorado, Ohio, Kentucky, North Carolina Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,615, issued on Nov. 25, was assigned to Akebia Therapeutics Inc. (Cambridge, Mass.).

"Prolyl hydroxylase inhibitors and methods of use" was invented by Richard Masaru Kawamoto (Divide, Colo.), Shengde Wu (West Chester, Ohio), Artem G. Evdokimov (Foristell, Mo.), Kenneth D. Greis (Fort Thomas, Ky.), Angelique Sun Boyer (West Chester, Ohio) and Namal C. Warshakoon (Cary, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to HIF-1Alpha prolyl hydroxylase inhibitors, compositions which comprise the HIF-1Alpha prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Dis...